| Product Code: ETC12999860 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Polycystic Kidney Disease Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Polycystic Kidney Disease Market - Industry Life Cycle |
3.4 Vietnam Polycystic Kidney Disease Market - Porter's Five Forces |
3.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
3.9 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Vietnam Polycystic Kidney Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about polycystic kidney disease in Vietnam |
4.2.2 Growing prevalence of polycystic kidney disease patients in the country |
4.2.3 Improving healthcare infrastructure and access to treatment options in Vietnam |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for polycystic kidney disease management |
4.3.2 High costs associated with treatment and medications for polycystic kidney disease in Vietnam |
5 Vietnam Polycystic Kidney Disease Market Trends |
6 Vietnam Polycystic Kidney Disease Market, By Types |
6.1 Vietnam Polycystic Kidney Disease Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Vasopressin Receptor Antagonists, 2021 - 2031F |
6.1.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By mTOR Inhibitors, 2021 - 2031F |
6.1.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By ACE Inhibitors, 2021 - 2031F |
6.1.6 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By ARBs, 2021 - 2031F |
6.2 Vietnam Polycystic Kidney Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Dialysis, 2021 - 2031F |
6.2.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Kidney Transplant, 2021 - 2031F |
6.2.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Lifestyle Modifications, 2021 - 2031F |
6.2.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Supportive Therapy, 2021 - 2031F |
6.3 Vietnam Polycystic Kidney Disease Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.4 Vietnam Polycystic Kidney Disease Market, By Diagnosis Type |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Imaging Tests, 2021 - 2031F |
6.4.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.4.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Biopsy, 2021 - 2031F |
6.4.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Urine Tests, 2021 - 2031F |
6.5 Vietnam Polycystic Kidney Disease Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.5.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Others, 2021 - 2031F |
7 Vietnam Polycystic Kidney Disease Market Import-Export Trade Statistics |
7.1 Vietnam Polycystic Kidney Disease Market Export to Major Countries |
7.2 Vietnam Polycystic Kidney Disease Market Imports from Major Countries |
8 Vietnam Polycystic Kidney Disease Market Key Performance Indicators |
8.1 Number of patients diagnosed with polycystic kidney disease annually |
8.2 Percentage of polycystic kidney disease patients receiving appropriate treatment |
8.3 Average waiting time for patients to access specialized care for polycystic kidney disease |
9 Vietnam Polycystic Kidney Disease Market - Opportunity Assessment |
9.1 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Diagnosis Type, 2021 & 2031F |
9.5 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Vietnam Polycystic Kidney Disease Market - Competitive Landscape |
10.1 Vietnam Polycystic Kidney Disease Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Polycystic Kidney Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here